Type . | Example . | Onset . | Peak . | Duration . |
---|---|---|---|---|
Short-acting | Regular/soluble | 30–60min | 1.5–3hr | 4–6hr |
Rapid (analogue) | Insulin lispro Insulin aspart | 5–30min 15–30min | 30–90min 1–3hr | 3–5hr 3–5hr |
Intermediate acti g | NPH Lente | 1–4hr 3–4hr | –10hr 6–12hr | 10–16hr 12–18hr |
Long-acting | Ultralente | 1–4hr | 8–16hr | 18–22hr |
Long-acting (analogue) | Insulin detemir Insulin glargine | 2–4hr –2hr | None None | 12–20hr 20–24hr |
Type . | Example . | Onset . | Peak . | Duration . |
---|---|---|---|---|
Short-acting | Regular/soluble | 30–60min | 1.5–3hr | 4–6hr |
Rapid (analogue) | Insulin lispro Insulin aspart | 5–30min 15–30min | 30–90min 1–3hr | 3–5hr 3–5hr |
Intermediate acti g | NPH Lente | 1–4hr 3–4hr | –10hr 6–12hr | 10–16hr 12–18hr |
Long-acting | Ultralente | 1–4hr | 8–16hr | 18–22hr |
Long-acting (analogue) | Insulin detemir Insulin glargine | 2–4hr –2hr | None None | 12–20hr 20–24hr |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.